Incyte to Report Third Quarter Financial Results
Incyte has scheduled its Q3 2020 financial results conference call for November 5, 2020, at 8:00 a.m. ET. The press release will precede the call, available at 7:00 a.m. ET. Investors can access the live webcast and slides through Incyte's investor relations website. Replay options are also provided for both domestic and international calls. The conference ID for the call is 13711777.
Incyte is dedicated to addressing serious medical needs through innovative therapeutics.
- None.
- None.
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursday, November 5, 2020.
The schedule for the press release and conference call/webcast is as follows:
• |
Q3 2020 Press Release: |
November 5, 2020 at 7:00 a.m. ET |
|||
|
|||||
• |
Q3 2020 Conference Call: |
November 5, 2020 at 8:00 a.m. ET | |||
• |
Domestic Dial-In Number: |
877-407-3042 | |||
• |
International Dial-In Number: |
201-389-0864 | |||
• |
Conference ID Number: |
13711777 |
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13711777.
The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 90 days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
